Back
Delegates Premium Access

Immune checkpoint inhibitor-associated myocarditis: clinical characteristics, management, and outcomes from a tertiary cardio-oncology unit

Session: Poster session (2)
Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer
Speaker: Doctor A. Pons Riverola (London, GB)
Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Alexandra Pons Riverola

Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
4 presentations
0 follower

59 more presentations in this session

Temporal trends and emerging burden of cardiovascular disease in cancer patients: A nationwide study from 2005 to 2022

Speaker: Doctor J. Cho (Seoul, KR)

Access
Abstract
Like
Thumbnail

Cardiovascular risk factors in oncology: A cross-sectional analysis of patients undergoing chemo-radiotherapy at a tertiary care center

Speaker: Doctor M. Canavera Ibanez (Bogota, CO)

Access
Abstract
Slides
Like
Thumbnail

Incidence of acute cardiovascular hospitalizations and association with hemodynamic biomarkers in cancer patients treated with Immune Checkpoint Inhibitor therapy

Speaker: Doctor A. Spannbauer (Vienna, AT)

Access
Abstract
Slides
Like
Thumbnail

Cardiovascular toxicity prediction in breast cancer patients: the HFA/ICOS risk tool in real-world practice

Speaker: Doctor B. Andrade (Santarem, PT)

Access
Abstract
Like
Thumbnail

Use of CMR in the assessment of cardiovascular reserve in patients treated with CAR-T therapy

Speaker: Doctor B. Aumente Rodriguez (Salamanca, ES)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session (2)

Speakers: Doctor A. Pons Riverola, Doctor J. Cho, Doctor M. Canavera Ibanez, Doctor A. Spannbauer, Doctor B. Andrade...
Access
Like
Thumbnail

About the event

Image

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources